<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01002599</url>
  </required_header>
  <id_info>
    <org_study_id>09-0160-B</org_study_id>
    <nct_id>NCT01002599</nct_id>
  </id_info>
  <brief_title>Oxygenation and Pulmonary Function in Morbidly Obese Patients Undergoing Bariatric Surgery</brief_title>
  <official_title>Does BoussignacTM CPAP Compared to Venturi Mask Improve Oxygenation and Pulmonary Function in Morbidly Obese Patients Undergoing Bariatric Surgery?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled study in which morbidly obese patients undergoing bariatric
      surgery will be recruited in the preoperative clinic. Patients will be randomized into 2
      groups to receive oxygen with Boussignac TM continuous positive airway pressure (CPAP) or
      conventional Venturi mask postoperatively immediately after extubation. The objective of the
      study is to examine if Boussignac TM CPAP results in improved oxygenation versus Venturi face
      mask when it is applied immediately after extubation in morbidly obese patients post
      bariatric surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">January 2010</completion_date>
  <primary_completion_date type="Anticipated">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PaO2/FiO2 ratio (PF ratio) immediately on arrival to postanesthesia care unit, 1 hour, 2 hours, and 24 hours post-extubation.</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>Boussignac TM CPAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Post-operative patients will be fitted with a Boussignac TM CPAP mask immediately after extubation and oxygenation and pulmonary function will be measured over a 24 hour period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Venturi Face Mask</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Post-operative patients will be fitted with a Venturi face mask immediately after extubation and oxygenation and pulmonary function will be measured over a 24 hour period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Boussignac TM CPAP</intervention_name>
    <description>Post-operative patients will be fitted with a Boussignac TM CPAP mask immediately after extubation and oxygenation and pulmonary function will be measured over a 24 hour period.</description>
    <arm_group_label>Boussignac TM CPAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Venturi Face Mask</intervention_name>
    <description>Post-operative patients will be fitted with a Venturi face mask immediately after extubation and oxygenation and pulmonary function will be measured over a 24 hour period.</description>
    <arm_group_label>Venturi Face Mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged between 18 to 75 years of age

          -  American Society of Anesthesiologists' (ASA) class I to III

          -  Morbidly obese with a body mass index &gt; 35 kg/m2

          -  Patients undergoing bariatric surgery

        Exclusion Criteria:

          -  Patient refusal

          -  Pre-existing cardiac failure, asthma, chronic obstructive pulmonary disease or
             interstitial pulmonary disease

          -  Systolic blood pressure less than 90 mmHg despite pharmacotherapy

          -  Hb &lt; 70 g/L

          -  Impaired gastric emptying

          -  Severe psychiatric disorder

          -  Language barrier
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David Wong, MD</last_name>
    <phone>4166035118</phone>
    <email>david.wong@uhn.on.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Wong, MD</last_name>
      <phone>4166035118</phone>
      <email>david.wong@uhn.on.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2009</study_first_submitted>
  <study_first_submitted_qc>October 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2009</study_first_posted>
  <last_update_submitted>January 22, 2010</last_update_submitted>
  <last_update_submitted_qc>January 22, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. David Wong</name_title>
    <organization>University Health Network</organization>
  </responsible_party>
  <keyword>bariatric surgery</keyword>
  <keyword>morbidly obese</keyword>
  <keyword>BMI &gt;35</keyword>
  <keyword>CPAP</keyword>
  <keyword>Venturi</keyword>
  <keyword>Boussignac</keyword>
  <keyword>Ventilation</keyword>
  <keyword>Pulmonary function</keyword>
  <keyword>Morbidly Obese Patients undergoing bariatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

